NEURONETICS INC (STIM)       3.18  +0.27 (+9.28%)

3.18  +0.27 (+9.28%)

US64131A1051 - Common Stock - After market: 3.47 +0.29 (+9.12%)

NEURONETICS INC3.18

NASDAQ:STIM (9/30/2022, 7:00:01 PM)+0.27 (+9.28%)

After market: 3.47 +0.29 (+9.12%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Equipment & Supplies
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 08-02 2022-08-02/bmo Earnings (Next) 11-07 2022-11-07
Ins Owners 8.17% Inst Owners 68.85%
Market Cap 85.93M Shares 27.02M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 80
IPO 06-28 2018-06-28

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

STIM Daily chart

Company Profile

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. The company is headquartered in Malvern, Pennsylvania and currently employs 184 full-time employees. The company went IPO on 2018-06-28. The firm is focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The firm intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The firm sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Company Info

NEURONETICS INC

31 General Warren Blvd.

Malvern PENNSYLVANIA 19355

P: 16106404202.0

CEO: Keith J. Sullivan

Employees: 184

Website: https://neurostar.com/neuronetics/

STIM News

News Image4 days ago - ChartmillWednesday's session: top gainers and losers

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

News Image5 days ago - ChartmillTuesday's pre-market session: top gainers and losers

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

News Image6 days ago - NeuroneticsNeuronetics Launches Innovations To NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform

Upgrades will enhance and automate the patient candidate experience for all NeuroStar providers, leading to faster patient identification of those in need...

News Image19 days ago - NeuroneticsNeuronetics, Inc. Announces Grand Opening of NeuroStar® University with Ribbon-Cutting Ceremony

The state-of-the-art training center is the first of its kind to further best practices with transformative NeuroStar Advanced Therapy for Mental Health...

News Imagea month ago - NeuroneticsNeuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Advanced Therapy for Mental Health

Latest NeuroStar innovation to simplify the motor threshold determination for clinicians...

News Image2 months ago - NeuroneticsNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

STIM Twits

Here you can normally see the latest stock twits on STIM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example